1st Quarter - Report

CAPITOL COUNSEL LLC for GENENTECH

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

340B issues and patient access to pharmaceuticals. Coronavirus response efforts, including related provisions in: (1) H.R. 6074, the Coronavirus Preparedness and Response Supplemental Appropriations Act; (2) H.R. 6201, the Families First Coronavirus Response Act; and (3) H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act.

Foreign entity interest: Foreign parent affected by policies affecting U.S. subsidiary.

LobbyistCovered position, as disclosed
CAITLIN CANTER —
AARON COHEN —
SHANNON FINLEY —
SARA FRANKO —
MARTIN B. GOLD —
LUKE HATZIS —
DENISE HENRY MORRISEY —
ANN JABLON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6074 (116th), H.R. 748 (116th), H.R. 6201 (116th)

Medicare/Medicaid MMM

Implementation issues affecting patient access to Medicare covered pharmaceuticals and reimbursement adequacy, including related provisions modifying Medicare Parts B and D benefit parameters, coverage, and reimbursement requirements in H.R. 3, the Lower Drug Costs Now Act and S. 2543, the Prescription Drug Pricing Reduction Act; use of step therapy in Medicare and health insurance coverage; and legislative efforts to modify the Center for Medicare & Medicaid Innovation to preserve patient access to medically-necessary treatments. Coronavirus response efforts, including related provisions in: (1) H.R. 6074, the Coronavirus Preparedness and Response Supplemental Appropriations Act; (2) H.R. 6201, the Families First Coronavirus Response Act; and (3) H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including related provisions in H.R. 5741, the Strengthening Innovation in Medicare and Medicaid Act.

Foreign entity interest: Foreign parent affected by policies affecting U.S. subsidiary.

LobbyistCovered position, as disclosed
CAITLIN CANTER —
AARON COHEN —
SHANNON FINLEY —
SARA FRANKO —
MARTIN B. GOLD —
LUKE HATZIS —
DENISE HENRY MORRISEY —
ANN JABLON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 748 (116th), S. 2543 (116th), H.R. 6201 (116th), H.R. 3 (116th), H.R. 5741 (116th), H.R. 6074 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.